TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34355232

Group type: EXPERIMENTAL
Intervention: Long-acting injectables (LAI)
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: Oral antipsychotics (OAP)
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 688

Group type: COMPARATOR
Intervention: Predictors of relapse
Number of subjects: 688
Study: 34406341

Group type: EXPERIMENTAL
Intervention: Femtosecond laser trabeculotomy (FLT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 12
Study: 36087612

Group type: EXPERIMENTAL
Intervention: PrEP adherence measured by tenofovir diphosphate concentrations of at least 700 fmol/punch
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: PrEP adherence measured by plasma tenofovir concentrations of at least 40 ng/mL
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Quantifiable concentrations of tenofovir diphosphate
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Quantifiable concentrations of tenofovir
Number of subjects: 427
Study: 35584248

Group type: EXPERIMENTAL
Intervention: SABER-Bupivacaine 5 mL
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo 5 mL
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Bupivacaine hydrochloride 20 mL
Number of subjects: 78
Study: 32805013

Group type: EXPERIMENTAL
Intervention: Kundalini yoga
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Stress education
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Kundalini yoga vs CBT
Number of subjects: 226
Study: 32004517

Group type: EXPERIMENTAL
Intervention: COMMENCE
Number of subjects: 102

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 102
Study: 36437222

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 34617892

Group type: EXPERIMENTAL
Intervention: Half Somersault Maneuver (HSM)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Epley Maneuver (EM)
Number of subjects: 43
Study: 34405362

Group type: EXPERIMENTAL
Intervention: Streptokinase (50,000 IU in 100 ml normal saline)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 3% H2O2 (3% H2O2 in 100 ml normal saline in 1:10 dilution)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 30

Group type: COMPARATOR
Intervention: 3% H2O2
Number of subjects: 30
Study: 33686610

Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg single dose with 150 mg Mg2+
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg multiple doses with 75 mg Mg2+
Number of subjects: 51

Group type: COMPARATOR
Intervention: Tramadol without Mg2+
Number of subjects: 51
Study: 32084592

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) plus standard care (systemic anticoagulation and/or antiplatelet therapy)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) plus standard care
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 50
Study: 35120539

Group type: EXPERIMENTAL
Intervention: Peer-delivered relational intervention
Number of subjects: 68
Study: 34119535

Group type: EXPERIMENTAL
Intervention: Ranibizumab 100 μg/ml
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aflibercept 400 μg/ml
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conbercept 100 μg/ml
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3‐MA or CQ (autophagy inhibitors)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hypoxia group (1% O2, 5% CO2, 94% N2)
Number of subjects: 0
Study: 35382902

Group type: EXPERIMENTAL
Intervention: TheraBracelet with hand task practice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (hand task practice alone)
Number of subjects: 0
Study: 33496913

Group type: EXPERIMENTAL
Intervention: All implants
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Cluster analysis (143 patients)
Number of subjects: 456
Study: 35410256

Group type: EXPERIMENTAL
Intervention: Listening to music for 20 min in the pre‐ and postoperative period
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care in the pre‐ and postoperative period
Number of subjects: 0
Study: 33652307

Group type: EXPERIMENTAL
Intervention: Brightness Index (BI) from Landsat 8 images
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Brightness Index (BI)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: USLE (Universal Soil Loss Equation) soil loss
Number of subjects: 180
Study: 32521132

Group type: EXPERIMENTAL
Intervention: Givosiran (2.5 mg/kg, subcutaneous, monthly for 6 months)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Givosiran
Number of subjects: 94
Study: 35175249

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 5145
Study: 33859140

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 25

Group type: COMPARATOR
Intervention: 2% lidocaine (control)
Number of subjects: 25
Study: 34845313

Group type: EXPERIMENTAL
Intervention: 100 µg of vitamin K2 (MK‐7)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 10 µg of native vitamin D
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 100 µg of vitamin K2 (MK‐7) and 10 µg of native vitamin D
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard therapy only
Number of subjects: 60

Group type: COMPARATOR
Intervention: Healthy normal control
Number of subjects: 60
Study: 34721612

Group type: EXPERIMENTAL
Intervention: Abdominal crunch training protocol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Double straight leg raise (DSLR) exercise protocol
Number of subjects: 40
Study: 33686887

Group type: EXPERIMENTAL
Intervention: SilvrSTAT Gel dressing
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional dressing (wet-to-moist dressing with or without povidone-iodine)
Number of subjects: 80
Study: 34491651

Group type: EXPERIMENTAL
Intervention: Acupoint application of Zhanjin Huoxue formula combined with local cold compress (applied at specific acupoints, 4 hours each time, 2 times a day for 7 days)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Local cold compress (3 times a day for 7 days)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Acupoint application of Zhanjin Huoxue formula combined with local cold compress
Number of subjects: 62

Group type: COMPARATOR
Intervention: Local cold compress
Number of subjects: 62
Study: 32912951

Group type: EXPERIMENTAL
Intervention: Non-pharmacological components delivered before pharmacological components (Group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacological components followed by non-pharmacological components (Group B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (Group C)
Number of subjects: 0
Study: 35453051

Group type: EXPERIMENTAL
Intervention: Exposure to environmental pollutants (biomarkers including lead, DDT, PCBs, PAHs, regulated phthalates, BPA)
Number of subjects: 428

Group type: EXPERIMENTAL
Intervention: Household educational attainment and residential urbanicity as exposure determinants
Number of subjects: 428
Study: 33442988

Group type: EXPERIMENTAL
Intervention: Lifesaver VR training
Number of subjects: 352

Group type: COMPARATOR
Intervention: Face-to-face CPR training
Number of subjects: 352
Study: 32326757

Group type: EXPERIMENTAL
Intervention: Modified relative dose response (MRDR) test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Serum retinol measurement
Number of subjects: 0
Study: 33248910

Group type: EXPERIMENTAL
Intervention: High concentration nano-hydroxyapatite (nHAP) applied for 2 to 3 minutes daily for 10 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sandblasting with 50μm aluminium oxide and 30 seconds etching after nHAP application
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 60 seconds etching after nHAP application
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 30 seconds etching after nHAP application
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no nHAP application)
Number of subjects: 60
Study: 32816944

Group type: EXPERIMENTAL
Intervention: Bevacizumab 7.5 mg/kg infusion with cisplatin and gemcitabine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bevacizumab 2.5 mg/kg infusion with cisplatin and gemcitabine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sunitinib 12.5 mg/day with cisplatin and gemcitabine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sunitinib 25 mg/day with cisplatin and gemcitabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cisplatin and gemcitabine chemotherapy without anti-VEGF therapy
Number of subjects: 0
Study: 36012033

Group type: EXPERIMENTAL
Intervention: EMG rehabilitation robot
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 0
Study: 33672550

Group type: EXPERIMENTAL
Intervention: Cycling intervention (four cycling sessions; 1–2 h per session, one session per week)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control group (usual activities)
Number of subjects: 360
Study: 33128006

Group type: EXPERIMENTAL
Intervention: Self-reported walking pace
Number of subjects: 450967
Study: 37142462

Group type: EXPERIMENTAL
Intervention: Rapid vaccination schedule (group R)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Accelerated conventional vaccination schedule (group A)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Conventional vaccination schedule (group C)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: All groups (≥50 years old)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: All groups (≥60 years old)
Number of subjects: 194
Study: 35090433

Group type: EXPERIMENTAL
Intervention: Culturally targeted stress management-enhanced behavioral weight loss intervention (BWL-Stress)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Behavioral weight loss intervention alone (BWL-alone)
Number of subjects: 340
Study: 35242594

Group type: EXPERIMENTAL
Intervention: Blended cognitive-behavioral therapy (CBT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standard cognitive-behavioral therapy (CBT)
Number of subjects: 76
Study: 35157993

Group type: EXPERIMENTAL
Intervention: New NRG/RTOG contouring guidelines
Number of subjects: 300

Group type: COMPARATOR
Intervention: Old RTOG/PARCER contouring guidelines
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Local treatment after relapse
Number of subjects: 300

Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 300
Study: 33606270

Group type: EXPERIMENTAL
Intervention: Lower TSH MoM
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Lower TSH
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Gestational transient thyrotoxicosis
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: TSH and FT4
Number of subjects: 215
Study: 35771652

Group type: EXPERIMENTAL
Intervention: Rapid expansion (RME)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Slow expansion (SME)
Number of subjects: 30
Study: 33838224

Group type: EXPERIMENTAL
Intervention: Standard treatment plus TPE (n=43)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Standard treatment (n=44)
Number of subjects: 87
Study: 33596856

Group type: EXPERIMENTAL
Intervention: Psychoanalytic psychotherapy with transference work (N = 39)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Psychoanalytic psychotherapy without transference work (N = 31)
Number of subjects: 69
Study: 32687161

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01B or RTS,S/AS01E (3 doses on a 0-1-7-month schedule, with the final 1 or 2 doses being fractional)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01E (2 doses: 1 full at month 0 and 1 fractional at month 7)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (unvaccinated participants)
Number of subjects: 130
Study: 35166571

Group type: EXPERIMENTAL
Intervention: Breastfeeding self-efficacy during pregnancy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Study arm (control group not specified)
Number of subjects: 50
Study: 34491285

Group type: EXPERIMENTAL
Intervention: Screen time permitted group
Number of subjects: 125

Group type: COMPARATOR
Intervention: Screen time abstinent group
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 125
Study: 35560464

Group type: EXPERIMENTAL
Intervention: Intermittent Hypoxia (IH) protocol with eight 4-minute hypoxic cycles at targeted arterial oxygen saturation of 80%
Number of subjects: 9

Group type: COMPARATOR
Intervention: Intermittent Normoxia (IN) protocol with eight 4-minute normoxic cycles
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intermittent Hypoxia (IH)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Intermittent Normoxia (IN)
Number of subjects: 9
Study: 33851430

Group type: EXPERIMENTAL
Intervention: Structured Inventory of Malingered Symptomatology (SIMS)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Miranda Quiz (MQ)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Revised Clinical ILK (RC-ILK)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Inventory of Legal Knowledge (ILK)
Number of subjects: 82
Study: 34905143

Group type: EXPERIMENTAL
Intervention: Full-thickness skin grafting (FTSG)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Synthetic mesh (SM)
Number of subjects: 52
Study: 33149114

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptives (COC)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Contraceptive vaginal ring (CCVR)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Injectable norethisterone enanthate (Net‐En)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 130
Study: 33151132

Group type: EXPERIMENTAL
Intervention: Saffron group (received routine care plus capsule of saffron 400 mg/day, 200 mg twice per day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (received routine stroke care)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Saffron group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 34259401

Group type: EXPERIMENTAL
Intervention: Tongdu Tiaoshen acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Estazolam tablets (1 mg)
Number of subjects: 60
Study: 32255785

Group type: EXPERIMENTAL
Intervention: PBM in the sublingual region
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: PBM over the radial artery
Number of subjects: 14
Study: 35237033

Group type: EXPERIMENTAL
Intervention: Liraglutide (3.0 mg, s.c.)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (s.c.)
Number of subjects: 40
Study: 34677593

Group type: EXPERIMENTAL
Intervention: 80 mg methylprednisolone
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: 40 mg methylprednisolone
Number of subjects: 111

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: 80 mg methylprednisolone vs placebo
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: 40 mg methylprednisolone vs placebo
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: 80 mg methylprednisolone vs 40 mg methylprednisolone
Number of subjects: 111
Study: 32789619

Group type: EXPERIMENTAL
Intervention: Transvenous phrenic nerve stimulation (TPNS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 32331064

Group type: EXPERIMENTAL
Intervention: 100 mg SPN-812
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: 200 mg SPN-812
Number of subjects: 477

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 477
Study: 33586178

Group type: EXPERIMENTAL
Intervention: Online psychoeducational stress management program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 36244384

Group type: EXPERIMENTAL
Intervention: Aqueous 10% povidone‐iodine
Number of subjects: 1638

Group type: COMPARATOR
Intervention: Aqueous 4% chlorhexidine gluconate
Number of subjects: 1638
Study: 34499788

Group type: EXPERIMENTAL
Intervention: Intraoral mask
Number of subjects: 36

Group type: COMPARATOR
Intervention: Classic face mask
Number of subjects: 36
Study: 32839843

Group type: EXPERIMENTAL
Intervention: Denosumab treatment
Number of subjects: 0
Study: 35780115

Group type: EXPERIMENTAL
Intervention: eModule (interactive learning activity)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Wikipedia-like page (non-interactive learning activity)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: eModule
Number of subjects: 32

Group type: COMPARATOR
Intervention: Wikipedia-like page
Number of subjects: 32
Study: 33836772

Group type: EXPERIMENTAL
Intervention: Mass Screening and Treatment (MST) intervention
Number of subjects: 1551
Study: 36093566

Group type: EXPERIMENTAL
Intervention: 100 μg selenium as selenium-enriched yeast daily
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: 200 μg selenium as selenium-enriched yeast daily
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: 300 μg selenium as selenium-enriched yeast daily
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: 100, 200, or 300 μg selenium as selenium-enriched yeast daily
Number of subjects: 481

Group type: COMPARATOR
Intervention: Placebo-yeast
Number of subjects: 481
Study: 33609973

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (AC) in high-risk patients (34.4%, n = 166)
Number of subjects: 1040

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (AC) in low-risk patients (36.5%, n = 203)
Number of subjects: 1040

Group type: COMPARATOR
Intervention: High-risk stage II AA
Number of subjects: 1040
Study: 32244970

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Conference Call (CBCC)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Behavioral-Activation Conference Call (BACC)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Usual Care Control Group (CG)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: BACC
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: CBCC
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: CBCC vs BACC
Number of subjects: 219
Study: 36145126

Group type: EXPERIMENTAL
Intervention: Oral vitamin B1 and mecobalamin, artificial tears
Number of subjects: 199

Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 199
Study: 33351971

Group type: EXPERIMENTAL
Intervention: HTL0018318 (1–35 mg)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 35658869

Group type: EXPERIMENTAL
Intervention: 5R Shared Leadership Program (5RS) in addition to regular group walking
Number of subjects: 503

Group type: COMPARATOR
Intervention: Regular group walking program
Number of subjects: 503
Study: 32275025

Group type: EXPERIMENTAL
Intervention: Propofol-dexmedetomidine continuous infusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol continuous infusion
Number of subjects: 60
Study: 35758017

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) 0.3 g/kg body mass
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 33577276

Group type: EXPERIMENTAL
Intervention: C-loop IOL (CT LUCIA 611P)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 4-point haptic IOL (CT ASPHINA 409MP)
Number of subjects: 50
Study: 35483028

Group type: EXPERIMENTAL
Intervention: Trans-radial approach (TRA)
Number of subjects: 20122
Study: 33848462

Group type: EXPERIMENTAL
Intervention: Copanlisib plus rituximab
Number of subjects: 458

Group type: COMPARATOR
Intervention: Placebo plus rituximab
Number of subjects: 458
Study: 35013506

Group type: EXPERIMENTAL
Intervention: brief motivational intervention (bMI)
Number of subjects: 88

Group type: COMPARATOR
Intervention: breastfeeding education (control)
Number of subjects: 88
Study: 33713629

Group type: COMPARATOR
Intervention: Theoretical training (Group A)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Theoretical and practical training (Group B)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Theoretical and practical training (Group C)
Number of subjects: 42

Group type: COMPARATOR
Intervention: All groups (A, B, C)
Number of subjects: 42
Study: 34980562

Group type: EXPERIMENTAL
Intervention: Health literacy-based group education and phone counseling for 12 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine diabetic care
Number of subjects: 120
Study: 33677935

Group type: EXPERIMENTAL
Intervention: Diabetes Fibrosis Score (DFS)
Number of subjects: 766

Group type: COMPARATOR
Intervention: Conventional fibrosis scores (NFS, FIB-4, APRI)
Number of subjects: 766
Study: 35082320

Group type: EXPERIMENTAL
Intervention: Continuous quality improvement interventions (CQI) for prevention of mother-to-child transmission (PMTCT) of HIV
Number of subjects: 0
Study: 36069840

Group type: EXPERIMENTAL
Intervention: PA-first group (4-week PA intervention followed by 4-week FVC intervention)
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: FVC-first group (4-week FVC intervention followed by 4-week PA intervention)
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Intervention groups (PA-first and FVC-first)
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Changes in PA self-efficacy and FVC intention
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Changes in FVC intention
Number of subjects: 552

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 552
Study: 32359348

Group type: EXPERIMENTAL
Intervention: Butorphanol at the ED95 dose (9.07 μg/kg)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sufentanil at the ED95 dose (0.1 μg/kg)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both butorphanol and sufentanil
Number of subjects: 200
Study: 34590159

Group type: EXPERIMENTAL
Intervention: Individualised glucose control (IC group) targeting pre-admission usual glycaemia using glycated haemoglobin A1c level at ICU admission.
Number of subjects: 2075

Group type: COMPARATOR
Intervention: Conventional glucose control (CC group) maintaining glycaemia below 180 mg/dL.
Number of subjects: 2075

Group type: EXPERIMENTAL
Intervention: Post hoc analysis for non-diabetic patients in IC group.
Number of subjects: 2075
Study: 35230488

Group type: EXPERIMENTAL
Intervention: delgocitinib ointment 30 mg/g (n = 20)
Number of subjects: 31

Group type: COMPARATOR
Intervention: vehicle ointment (n = 11)
Number of subjects: 31
Study: 33352007

Group type: EXPERIMENTAL
Intervention: Exercise program combined with manual therapy (mobilization group)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Exercise therapy only (control group)
Number of subjects: 42